Differential antinociceptive effects of buprenorphine and methadone in the presence of HIV-gp120

Drug and Alcohol Dependence

Volumn 118, Issue 2-3, 2011, Pages 497-499

  Palma, Jonathan ^a   Cowan, Alan ^a   Geller, Ellen B ^a   Adler, Martin W ^a   Benamar, Khalid ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antinociception; Buprenorphine; Chemokine; Gp120; HIV; PAG

Indexed keywords

BUPRENORPHINE; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; METHADONE; STAINLESS STEEL; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CANNULA; CONTROLLED STUDY; DRUG EFFICACY; HOT PLATE TEST; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; NOCICEPTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; VIRUS STRAIN;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; HIV ENVELOPE PROTEIN GP120; HOT TEMPERATURE; MALE; METHADONE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS;

EID: 80053560059     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.04.010     Document Type: Article

References (21)

1. Adler M.W., Rogers T.J. Are chemokines the third major system in the brain?. J. Leukoc. Biol. 2005, 78:1204-1209.
2. Banisadr G., Skrzydelski D., Kitabgi P., Rostène W., Parsadaniantz S.M. Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur. J. Neurosci. 2003, 18:1593-1606.
3. Benamar K., Rawls S.M., Geller E.B., Adler M.W. Intrahypothalamic injection of deltorphin-II alters body temperature in rats. Brain Res. 2004, 1019:22-27.
4. Benamar K., Palma J., Cowan A., Geller E.B., Adler M.W. Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1α/CXCL12 in the brain. Drug Alcohol Depend 2011, 114:246-248.
5. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 1999, 17:657-700.
6. Chen X., Geller E.B., Rogers T.J., Adler M.W. Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats. Drug Alcohol Depend. 2007, 88:36-41.
7. Dahan A., Yassen A., Bijl H., Romberg R., Sarton E., Teppema L., Olofsen E., Danhof M. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br. J. Anaesth. 2005, 94:825-834.
8. Franchi S., Panerai A.E., Sacerdote P. Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment. Brain Behav. Immun. 2007, 21:767-774.
9. Gomez-Flores R., Weber R.J. Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology 2000, 48:145-156.
10. Heinisch S., Palma J., Kirby L.G. Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periaqueductal grey. Brain Behav. Immun. 2011, 25:360-372.
11. Martucci C., Panerai A.E., Sacerdote P. Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses. Pain 2004, 110:385-392.
12. Milligan E.D., Mehmert K.K., Hinde J.L., Harvey L.O., Martin D., Tracey K.J., Maier S.F., Watkins L.R. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 2000, 861:105-116.
13. Oh S.B., Tran P.B., Gillard S.E., Hurley R.W., Hammond D.L., Miller R.J. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J. Neurosci. 2001, 21:5027-5035.
14. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego.
15. Pergolizzi J., Aloisi A.M., Dahan A., Filitz J., Langford R., Likar R., Mercadante S., Morlion B., Raffa R.B., Sabatowski R., Sacerdote P., Torres L.M., Weinbroum A.A. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract. 2010, 10:428-450.
16. Shimizu N., Soda Y., Kanbe K., Liu H.Y., Mukai R., Kitamura T., Hoshino H. A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses. J. Virol. 2000, 74:619-626.
17. Sacerdote P., Franchi S., Gerra G., Leccese V., Panerai A.E., Somaini L. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function. Brain Behav. Immun. 2008, 22:606-613.
18. Scarlatti G., Burastero S., Tambussi G., Colognesi C., Quillent C., Longhi R., Loverro P., Borgonovo B., Gaffi D., Carrow E., Malnati M., Lusso P., Siccardi A.G., Lazzarin A., Beretta A. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. J. Exp. Med. 1997, 186:455-460.
19. Robinson S.E. Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction. CNS Drug Rev. 2002, 8:377-390.
20. Walsh S.L., Eissenberg T. The clinical pharmacology of buprenorphine: Extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003, 70:13-27.
21. Walsh S.L., June H.L., Schuh K.J., Preston K.L., Bigelow G.E., Stitzer M.L. Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacology 1995, 119:268-276.